Stockreport

Gilead Sciences (GILD) Is Up 11.0% After Trodelvy Combo Outperforms Keytruda Chemo In Phase 3 Trial - Has The Bull Case Changed? [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF improved progression-free survival over Keytruda plus chemotherapy in first-line PD-L1+ metastatic triple-negative breast cancer. This outcome, supported by supplement [Read more]